End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice

New therapeutic approaches for castration-resistant prostate cancer (CRPC) introduce new treatment dilemmas: how best to sequence these options to maximally benefit patients, what tests to perform before and after treatment to assess disease status, and how to interpret the test results and use them...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Scher, Howard I., Morris, Michael J., Basch, Ethan, Heller, Glenn
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2011
Témata:
Special Series: Prostate Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3675708/
https://ncbi.nlm.nih.gov/pubmed/21859988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.35.8648
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky